IEL B-cells: Phenotype and Developmental Requirements

IEL B 细胞：表型和发育要求

• 批准号: 6747497
• 负责人: Peter Velazquez
• 金额: $ 2.8万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-05-01 至 2006-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6747497
• 关键词: B cell receptor; B lymphocyte; biological signal transduction; developmental immunology; enteric bacteria; flow cytometry; gastrointestinal epithelium; immune response; immunofluorescence technique; immunogenetics; immunoregulation; laboratory mouse; mucosal immunity; phenotype; predoctoral investigator; protein structure function; toll like receptor

DESCRIPTION (provided by applicant): Immunologic homeostasis in the gastrointestinal (GI) tract involves the attenuation of inflammation in a compartment with more than 100 trillion bacteria. Homeostasis involves a variety of traits expressed by the host and the enteric bacterial commensals. The loss of this balance results in clinically important chronic mucosal inflammatory disorders, but the specific factors responsible for maintaining GI homeostasis are only partly understood. One emerging protective population is the mucosal B-cell, based on models of oral tolerance, chronic respiratory disease, and colitis. In this project, I characterize the functional phenotype and developmental requirements for a newly appreciated population at the host-bacterial interface, the intestinal intraepithelial lymphocyte (IEL) B-cell. Through genetic requirements, I will clarify the precursor B-cells filling this compartment. Through enteric bacterial and host genetic manipulations, I will determine how the formation/survival of this population is controlled by lumenal bacterial sensing by the TLR and B cell antigen receptor systems. My preliminary results support the feasibility of my key aims, and for a novel role of IEL B-cells in mucosal immune physiology.

描述（由申请人提供）：胃肠道（GI）中的免疫稳态涉及在具有超过100万亿细菌的隔室中减轻炎症。体内平衡涉及宿主和肠道细菌表达的多种特征。这种平衡的丧失导致临床上重要的慢性粘膜炎性疾病，但负责维持GI稳态的特定因素仅部分了解。一个新兴的保护性群体是粘膜B细胞，基于口服耐受、慢性呼吸道疾病和结肠炎的模型。在这个项目中，我的特点的功能表型和发展的要求，一个新的赞赏人口在宿主细菌界面，肠上皮内淋巴细胞（IEL）B细胞。通过遗传要求，我将阐明充满这个隔间的前体B细胞。通过肠道细菌和宿主的遗传操作，我将确定如何形成/生存的人口是由内腔细菌的TLR和B细胞抗原受体系统的传感控制。我的初步结果支持我的主要目标的可行性，并为一个新的作用IEL B细胞在粘膜免疫生理学。